RT Journal Article
SR Electronic
T1 Early Mandated Social Distancing is a Strong Predictor of Reduction in Highest Number of New COVID-19 cases per Day within Various Geographic Regions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.07.20094607
DO 10.1101/2020.05.07.20094607
A1 Qureshi, Adnan I.
A1 Suri, M. Fareed K.
A1 Chu, Haitao
A1 Suri, Habibullah Khan
A1 Suri, Ayehsa Khan
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.07.20094607.abstract
AB Mandated social distancing has been globally applied to limit the spread of corona virus disease 2019 (COVID-19) from highly pathogenic severe acute respiratory syndrome (SARS)-associated coronavirus 2 (SARS-CoV-2). The benefit of this community-based intervention in limiting COVID-19 has not been proven nor quantified. We examined the effect of timing of mandated social distancing on the rate of COVID-19 in 119 geographic regions derived from 41 states within United States and 78 countries. We found that highest number of new COVID-19 cases per day per million persons was significantly associated with total number of COVID-19 cases per million persons on the day before mandated social distancing (β=0.66, p<0.0001). Our findings suggest that the initiation of mandated social distancing for each doubling in number of existing COVID-19 cases would result in eventual peak with 58% higher number of COVID-19 infections per day. Subgroup analysis on those regions where the highest number of new COVID-19 cases per day have peaked increased β to .85 (p<0.0001). We demonstrate that initiating mandated social distancing at a 10 times smaller number of COVID-19 cases will reduce the number of daily new COVID-19 cases at peak by 80% highlighting the importance of this community-based intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding supported this workAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used for the analysis is either publicly available or included in the manuscript. I am in possession of all the data used in the manuscript and can provide upon request.